
Nefdapa 10 Tablet
Marketer
Hospimax Healthcare Pvt Ltd
Salt Composition
Dapagliflozin (10mg)
Overview Nefdapa 10 Tablet
Dapagliflozin 10mg tablets are prescribed, either independently or alongside other medications, for managing type 2 diabetes. This medication assists in regulating elevated blood glucose, thereby lessening the likelihood of severe diabetic complications and contributing to heart disease prevention. Dapagliflozin 10mg tablets may be ingested with or without food, at any time of day, but consistent daily timing is recommended. Dosage is determined by your physician; discontinuation requires medical consultation, as cessation can elevate blood sugar levels, risking serious consequences such as renal impairment and vision loss. This drug forms part of a comprehensive treatment plan encompassing a balanced diet, regular physical activity, and weight management, all under your doctor's guidance. Common adverse effects may include vaginal yeast infections, nasopharyngitis, and urinary tract infections. Increased fluid loss is possible; adequate hydration is crucial to prevent dehydration. Practicing good hygiene helps mitigate the risk of genital fungal infections. Prior to commencing treatment, disclose any kidney or liver issues, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals should consult their physician before use. Limit alcohol consumption as it may exacerbate side effects. Regular blood glucose monitoring is essential during treatment.
Primary Ingredients of Nefdapa 10 Tablet
There is no text provided to rephrase.
Uses of Nefdapa 10 Tablet
Managing type 2 diabetes
Major Benefits of Nefdapa 10 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Nefdapa 10 Tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, however, consistent timing is recommended.
Common Side effects of Nefdapa 10 Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Nefdapa 10 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Nefdapa 10 Tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, however, consistent timing is recommended.
How Nefdapa 10 Tablet works:
Nefdapa 10mg tablets are used to treat diabetes. Their mechanism of action involves the excretion of excess glucose via the urinary system.
SAFETY ADVICE
AlcoholUNSAFE
Combining Nefdapa 10 Tablet and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Nefdapa 10 Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against potential hazards prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding while taking Nefdapa 10 Tablet is potentially hazardous. Available human data indicates a possibility of the medication transferring to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyUNSAFE
The use of Nefdapa 10 Tablet is likely inadvisable for individuals with kidney impairment and should be omitted. Medical advice is recommended.
LiverSAFE IF PRESCRIBED
Nefdapa 10 Tablet poses no safety concerns for individuals with hepatic impairment. No alteration of Nefdapa 10 Tablet dosage is necessary.
What if you forget to take Nefdapa 10 Tablet :
Should you forget a Nefdapa 10 Tablet dose, administer it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Nefdapa 10 Tablet
Label | Value |
---|---|
Chemical Classification | Phenolic Glycoside Derivative |
Developing Habits | No. |
Treatment Category | Diabetes Management |
Actions | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |